SHANK1 and type 2 diabetes mellitus: A double knockout of Shank1 and Shank2 in mice has shown a significant reduction in the activation levels of the Akt signaling pathway [44], which is one of the primary signaling pathways involved in the pathogenesis of T2D and associated obesity [45].